Radio and PodcastRadio and PodcastLive Radio & Podcasts
Vepdegestrant artwork
Science & Medicine

Vepdegestrant

OncoPharm by OncoPharmPod

May 7, 202600:11:35Science & Medicine

The latest FDA drug approval is vepdegestrant, a heterobifunctional protein degrader, for ESR1 mutated breast cancer. We discuss what that actually means and some possible implications for clinical practice. Check out th...

About This Episode

Vepdegestrant is an episode from OncoPharm by OncoPharmPod. The latest FDA drug approval is vepdegestrant, a heterobifunctional protein degrader, for ESR1 mutated breast cancer. We discuss what that actually means and some possible implicat...

Podcast

This episode belongs to OncoPharm.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published May 7, 2026, 00:11:35 long, audio available.

Questions About This Episode

What is Vepdegestrant about?

The latest FDA drug approval is vepdegestrant, a heterobifunctional protein degrader, for ESR1 mutated breast cancer. We discuss what that actually means and some possible implications for clinical practice. Check out the Oncology Insights Newsletter:

Where can I listen to Vepdegestrant?

You can listen to Vepdegestrant online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Vepdegestrant from?

Vepdegestrant is an episode from OncoPharm by OncoPharmPod.

How long is this episode?

This episode is 00:11:35 long.

When was this episode published?

This episode was published on May 7, 2026.

Can I save Vepdegestrant for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from OncoPharm?

Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.